Skip to main navigation Skip to search Skip to main content

Successful allogeneic stem cell transplantation in second chronic-phase CML induced by the tyrosine kinase inhibitor nilotinib (AMN107) after blast crisis under imatinib [1]

H. Menzel*, N. von Bubnoff, A. Hochhaus, C. Haferlach, C. Peschel, J. Duyster

*Corresponding author for this work
Original languageEnglish
JournalBone Marrow Transplantation
Volume40
Issue number1
Pages (from-to)83-84
Number of pages2
ISSN0268-3369
DOIs
Publication statusPublished - 07.2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this